Antiaging Quantum Living Income Statement (2017-2026) | AAQL

Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.00M0.00M0.00M0.00M0.01M0.00M0.00M0.00M0.01M0.20M0.17M0.15M0.29M0.29M0.39M0.34M0.01M
Cost of Revenue (Quarter)
600.00500.00760.0011.00165.000.01M0.01M0.37M0.06M0.07M0.14M0.07M
Gross Profit (Quarter)
0.00M0.00M900.000.00M0.01M0.00M0.00M0.00M0.01M-11.000.20M0.16M0.15M-0.08M0.23M0.32M0.20M-0.06M
Operating items
Research & Development (Quarter)
0.01M0.06M0.13M0.10M0.06M-0.14M0.01M0.03M0.08M0.04M
Selling, General & Administrative (Quarter)
0.02M0.01M0.02M0.02M0.01M0.01M0.01M0.03M0.02M0.09M0.20M0.28M0.26M0.28M0.24M0.36M0.35M0.40M0.27M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
0.02M0.01M0.02M0.02M0.01M0.01M0.01M0.03M0.02M0.10M0.26M0.42M0.36M0.35M0.10M0.37M0.38M0.48M0.31M
Operating Income (Quarter)
-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.20M-0.18M-0.14M-0.05M-0.27M-0.37M
EBIT (Quarter)
-0.01M-0.01M-0.02M-0.00M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.20M-0.18M-0.14M-0.05M-0.27M-0.37M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
873.00701.002.0043.0025.0022.0014.0018.0021.0012.0073.0057.00
Other Non Operating Income (Quarter)
1.000.07M-175.000.01M57.0053.000.00M
Non Operating Income (Quarter)
873.00701.003.0043.0025.0022.000.07M-157.000.01M69.00126.000.00M
Net income details
EBT (Quarter)
-0.01M-0.01M-0.02M-0.00M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.05M-0.27M-0.37M
Tax Provisions (Quarter)
0.01M0.01M55.00160.00
Profit After Tax (Quarter)
-0.01M-0.01M-0.02M-0.00M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M0.19M-0.25M-0.38M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)
-0.01M-0.01M-0.02M-0.00M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.06M-0.27M-0.37M
Consolidated Net Income (Quarter)
-0.01M-0.01M-0.02M-0.00M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.06M-0.27M-0.37M
Income towards Parent Company (Quarter)
-0.01M-0.01M-0.02M-0.00M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.06M-0.27M-0.37M
Net Income towards Common Stockholders (Quarter)
-0.01M-0.01M-0.02M-0.00M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.06M-0.27M-0.37M
Additional items
EPS (Basic) (Quarter)
0.000.000.000.000.000.000.000.000.000.000.00-0.01-0.01-0.010.00-0.010.000.00-0.01-0.01
EPS (Diluted) (Quarter)
0.000.000.000.000.000.000.00-0.01-0.01-0.010.00-0.010.000.00-0.01-0.01
Shares Outstanding (Quarter)
30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M29.95M30.00M30.00M30.00M30.00M30.00M31.72M31.48M
Shares Outstanding (Diluted) (Quarter)
30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M29.95M30.00M30.00M30.00M30.00M30.00M31.72M31.48M
Shares Outstanding (Entity) (Quarter)
30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M34.28M34.28M
EBITDA (Quarter)
-0.01M-0.01M-0.02M-0.00M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.20M-0.18M-0.14M-0.05M-0.27M-0.37M
Interest Expenses (Quarter)
0.02M-0.00M0.32M0.00M0.08M0.33M0.50M0.09M0.08M0.02M
Tax Rate (Quarter)
-4.71%-20.42%-0.02%-0.04%